Neurodevelopment of Critical ILL Neonates at the Age of 12 Months

Area of Science:

• Neonatalogy
• Pediatric Neurology
• Developmental Pediatrics

Background:

• Critically ill neonates face long-term neurological and developmental challenges, including cerebral palsy and cognitive deficits.
• Hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal brain injury, often accompanied by comorbidities.
• Assessing psychomotor development is vital for identifying deficits and guiding early interventions.

Purpose of the Study:

• To investigate the psychomotor development of children with HIE and associated comorbidities.
• To identify factors influencing neurodevelopmental outcomes in survivors of neonatal critical illness.

Main Methods:

• Studied 20 children with HIE, including those with comorbidities like respiratory distress syndrome (RDS), infections, and metabolic disturbances.
• Utilized socio-demographic, pregnancy, delivery data, HIE/RDS staging tools, physical examination, Apgar scores, and blood gas analyses.
• Employed the Griffiths Mental Development Scale (GMDS) to assess psychomotor development across motor, language, cognitive, and social domains.

Main Results:

• 30% of children were diagnosed with cerebral palsy.
• At one year, 50% showed typical development, while 50% exhibited varying degrees of disability (mild 5%, moderate 20%, severe 25%).
• Severity of HIE, Apgar score, muscle tone, seizures, glucose homeostasis, and comorbidities (sepsis, infection) significantly impacted outcomes.

Conclusions:

• Neurodevelopmental outcomes in HIE survivors are influenced by disease severity and comorbidities.
• Early identification of psychomotor deficits using tools like GMDS is essential for timely intervention.
• Further research with larger cohorts is needed to refine early intervention strategies for critically ill neonates.